Puma Biotechnology, Inc. (NASDAQ: PBYI) is presenting updated results from a Phase II clinical trial of Puma's drug neratinib at the 2018 San Antonio ...
News
- Puma Biotech (PBYI) Highlights Updated Data from Patient Reported Outcomes in Phase II ...
- Recon: HHS Defends Drug Pricing Proposal; Mallinckrodt to Spin Off Specialty Generics Business
Pharmaceuticals & Biotechnology ... Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium (Press); Puma Biotechnology Presents ...
- New parasite decimates giant clam species in Mediterranean
"We cannot be sure of anything at this point," said Pantelis Katharios, senior researcher at the Institute of Marine Biology, Biotechnology and ...
- Let's make Texas the 'third coast' for biotech
Texas has made a name for itself in biotech by supporting premier ... In San Antonio, one of every six workers is employed in the city's flourishing ...
- Bb Biotech Ag Boosted Its Radius Health (RDUS) Holding; Bellway plc (LON:BWY) Covered By 8 ...
Bb Biotech Ag increased Radius Health Inc. (RDUS) stake by 5.93% .... San Antonio Breast Cancer Symposium (SABCS) – Nasdaq” on November 30, ...